New York State Common Retirement Fund Keros Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

  • $73.9 Billion
  • Q3 2024

A detailed history of New York State Common Retirement Fund transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 10,316 shares of KROS stock, worth $684,053. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,316
Previous 12,616 18.23%
Holding current value
$684,053
Previous $577,000 3.81%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024
SELL
$41.68 - $58.07 $95,864 - $133,561
-2,300 Reduced 18.23%
10,316 $599,000
Q2 2024

Jul 31, 2024
SELL
$44.58 - $66.89 $200,877 - $301,406
-4,506 Reduced 26.32%
12,616 $577,000
Q1 2024

May 07, 2024
BUY
$41.26 - $70.48 $281,764 - $481,307
6,829 Added 66.35%
17,122 $1.13 Million
Q4 2023

Feb 01, 2024
SELL
$27.12 - $41.05 $1,193 - $1,806
-44 Reduced 0.43%
10,293 $409,000
Q3 2023

Nov 07, 2023
BUY
$31.57 - $43.02 $2,904 - $3,957
92 Added 0.9%
10,337 $330,000
Q2 2023

Aug 07, 2023
BUY
$37.26 - $51.01 $6,632 - $9,079
178 Added 1.77%
10,245 $412,000
Q1 2023

May 02, 2023
SELL
$41.44 - $59.32 $123,698 - $177,070
-2,985 Reduced 22.87%
10,067 $430,000
Q4 2022

Jan 30, 2023
BUY
$39.45 - $51.77 $19,448 - $25,522
493 Added 3.93%
13,052 $627,000
Q3 2022

Nov 08, 2022
BUY
$27.8 - $40.12 $42,951 - $61,985
1,545 Added 14.03%
12,559 $472,000
Q2 2022

Aug 04, 2022
SELL
$26.03 - $67.04 $598 - $1,541
-23 Reduced 0.21%
11,014 $304,000
Q1 2022

May 05, 2022
BUY
$42.12 - $59.36 $421 - $593
10 Added 0.09%
11,037 $600,000
Q4 2021

Feb 02, 2022
SELL
$36.95 - $62.89 $1,145 - $1,949
-31 Reduced 0.28%
11,027 $645,000
Q3 2021

Nov 02, 2021
SELL
$29.27 - $43.71 $94,951 - $141,795
-3,244 Reduced 22.68%
11,058 $437,000
Q2 2021

Aug 02, 2021
BUY
$42.4 - $70.11 $101,844 - $168,404
2,402 Added 20.18%
14,302 $607,000
Q1 2021

May 11, 2021
BUY
$54.0 - $75.28 $43,200 - $60,224
800 Added 7.21%
11,900 $732,000
Q4 2020

Feb 08, 2021
BUY
$36.0 - $82.74 $169,200 - $388,878
4,700 Added 73.44%
11,100 $783,000
Q2 2020

Aug 07, 2020
BUY
$20.08 - $40.39 $128,511 - $258,496
6,400 New
6,400 $240,000

Others Institutions Holding KROS

# of Institutions
174
Shares Held
30.3M
Call Options Held
76.8K
Put Options Held
9K
View Full List

About Keros Therapeutics, Inc.

KROS Quotes by TradingView
  • Ticker KROS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,757,000
  • Market Cap $1.71B
  • Description
  • Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...
More about KROS
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email